-
Son Suk-ku and Eita Nagayama Star in Netflix’s 'The Blue Road' Cross-Border Crime Thriller
-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Moving to a New State? Your Healthcare Might Get More Complicated
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
South Africa’s Economic Shift: Why Services Must Lead Job Creation Beyond Manufacturing
-
5 Strategies for Fort Worth Households to Reduce Summer Electricity Costs
-
Lethbridge Council to Vote on $80 Million Capital Improvement Program
-
Central Bank of Malta Links Energy Subsidies to Middle East Conflict and Price Volatility
-
Redmi Note 18 5G Battery Specs Leaked: Larger Capacity in Chinese Variant
-
Shomari Figures Defies Redistricting in Alabama Amid Disaster Relief Crisis
-
COP31 Presidency Publishes First Draft Cover Decision on Climate Action
-
BYD Dolphin G Leasing Deal: Plug-in Hybrid Supermini Available from £174 a Month
-
EU Club Group Files Antitrust Complaint Against UEFA Over Prize Money
-
Egypt Opens Registration for 2027 Total Solar Eclipse Viewing Packages
-
Heat and El Niño Drive Surge in Preterm Births Across Southern Africa
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Tom Brady’s Viral Reaction to Deebo Samuel’s Trick-Play Touchdown
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
13 Native American-Owned Restaurants in Arizona to Experience Indigenous Culinary Traditions
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Best Digital Photo Frames 2026: Aura, Skylight, and Amazon Compared
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
No decision on Sinner doping case before new year - WADA
Tennis star Jannik Sinner's doping case will not have a decision from the Court of Arbitration for Sport (CAS) before the end of the year, the World Anti-Doping Agency (WADA) told AFP.
"There will be nothing by the end of the year," WADA director general Olivier Niggli said in an interview with AFP.
The Italian world number one twice tested positive for traces of the banned substance clostebol in March but was exonerated and allowed to carry on playing.
An independent tribunal at the end of August, requested by the International Tennis Integrity Agency (ITIA) found that the Australian Open and US Open champion "bears no fault or negligence".
The ITIA accepted Sinner's explanation that the drug entered his system when his physiotherapist used a spray containing it to treat a cut, then provided massage and sports therapy to the player.
WADA have appealed the decision to clear the 23-year-old and are seeking a ban of up to two years.
"It was considered in the decision that there was no fault on the part of Sinner. Our position is that there is still a responsibility of the athlete in relation to his entourage," Niggli said.
"So it is this legal point that will be debated (before CAS).
"We do not dispute the fact that it could have been a contamination. But we believe that the application of the rules does not correspond to the case law."
While the ITIA were criticised for having revealed late the positive tests of Sinner and of women's world number two Iga Swiatek, Niggli believes that "athletes must be protected".
Swiatek last month accepted a one-month suspension after testing positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024.
"Personally, I think that protecting an athlete's reputation should be our first concern," said Niggli.
"We live in a world where social media is what it is and means that a reputation can go up in smoke in a very, very short time."
C.Bruderer--VB